Researchers at New York's Aaron Diamond AIDS Research Center have teamed with scientists and health officials in China's Yunan province, home to 35 million people, to develop China's largest HIV/AIDS treatment program, the South China Morning Post reports. The three-year project aims to offer antiretroviral drug therapy to about 300 HIV-positive people in the province. Currently, only about 250 people in the entire nation are taking anti-HIV drugs, according to Yunan health officials. Program participants will be given GlaxoSmithKline's once-a-day anti-HIV drug Trizivir, which contains AZT, 3TC, and Ziagen. The pharmaceutical company will donate the medication for the program.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved














